IP Verse

A Dosing Regime And Formulations For Type B Adenoviruses

Patent No. EP3007711 (titled "A Dosing Regime And Formulations For Type B Adenoviruses") was filed by Akamis BIO on Jun 12, 2014. The application was issued on Oct 21, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DEHNSJul 19, 2021DEHNS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3007711

AKAMIS BIO
Application Number
EP14736650A
Filing Date
Jun 12, 2014
Status
Revoked
Feb 21, 2025
Publication Date
Oct 21, 2020
External Links
Slate, Register , Google Patents